Press Releases

 
Press Releases
  Date Title View
Oct 9, 2017
EDAP to Market Echotherapy for ablation of breast fibroadenomas and benign thyroid nodules LYON, France, October 9, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the signature of an Agreement with French HIFU Company Theraclion, to exclusively distribute the Echopulse® system in France....
Oct 4, 2017
LYON, France, October 4, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced FDA approval of its Ablatherm-Fusion device enabling a more precise method for targeting of diagnosed areas within the prostate. Marc Oczachowski, Chief Executive Officer of EDAP TMS, commented: "We are very pleased with ...
Sep 19, 2017
University of Chicago Medicine - Dr. A. Shalhav, Chair of Urology Surgery and Director of Robotic Surgery Vituro Health LLC - Dr. S. Scionti, Medical Director and Director of The Scionti Prostate Center in Sarasota, FL LYON, France, September 19, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announce...
Sep 11, 2017
510(k) Includes New Clinical Data to Support EDAP's File LYON, France, September 11, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company submitted a new 510(k) application for its Focal One device, including an updated clinical section for FDA review.  As reported on July 17, 201...
Aug 31, 2017
Dr. S. Scionti, Medical Director of Vituro and most experienced HIFU urologist in the U.S. to start treating with Ablatherm in September LYON, France, August 31, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company signed a partnership agreement with Vituro Health LLC, an Alabama-base...
Aug 24, 2017
LYON, France, August 24, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski, Chief Executive Officer, will present at the 19th Annual Rodman & Renshaw Global Investment Conference to be held September 10-12, 2017 at the Lotte New York Palace Hotel, New York, New Yor...
Aug 23, 2017
EDAP-TMS Reports Record Second Quarter and First Half 2017 Results Revenue increased 13.7% to a record €9.3 million for the second quarter of 2017 compared to €8.2 million in 2016HIFU revenue grew 25% when compared to first quarter of 2017Ablatherm Fusion 510(k) submission completedC-Code reimbursement for HIFU treatments active...
Aug 10, 2017
PRESS RELEASE Contact: Blandine ConfortInvestor Relations / Legal AffairsEDAP TMS SA+33 4 72 15 31 72bconfort@edap-tms.com Investors:Rich CockrellCG CAPITAL877.889.1972rich@cg.capital   EDAP-TMS to Announce Second Quarter 2017 Financial Results on Wednesday, August 23, 2017 Conference Call to Review Results to be Held Thursday, August 2...
Jul 31, 2017
LYON, France, July 31, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company submitted a 510(k) application for its Ablatherm Fusion device, enabling a more precise method for targeting of diagnosed areas within the prostate. Marc Oczachowski, Chief Executive Officer of EDAP TMS, commente...
Jul 19, 2017
Webcast to be held Thursday, July 27th, 2017 LYON, France, July 18, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company plans to host an investor call with commentary from an American robotic surgeon and oncologist to discuss their hands-on experience with EDAP's HIFU...
1
... NextLast
= add release to Briefcase